The knee adduction moment is consistently used as a surrogate measure of medial compartment loading. Foot orthoses are designed to reduce knee adduction moment via lateral wedging. The 'dose' of wedging required to optimally unload the affected compartment is unknown and variable between individuals. This study explores a personalised approach via three-dimensional printed foot orthotics to assess the biomechanical response when two design variables are altered: orthotic length and lateral wedging. Foot orthoses were created for 10 individuals with symptomatic medial knee osteoarthritis and 10 controls. Computer-aided design software was used to design four full and four three-quarterlength foot orthoses per participant each with lateral posting of 0°'neutral', 5°rearfoot, 10°rearfoot and 5°forefoot/ 10°rearfoot. Three-dimensional printers were used to manufacture all foot orthoses. Three-dimensional gait analyses were performed and selected knee kinetics were analysed: first peak knee adduction moment, second peak knee adduction moment, first knee flexion moment and knee adduction moment impulse. Full-length foot orthoses provided greater reductions in first peak knee adduction moment (p = 0.038), second peak knee adduction moment (p = 0.018) and knee adduction moment impulse (p = 0.022) compared to three-quarter-length foot orthoses. Dose effect of lateral wedging was found for first peak knee adduction moment (p \ 0.001), second peak knee adduction moment (p \ 0.001) and knee adduction moment impulse (p \ 0.001) indicating greater unloading for higher wedging angles. Significant interaction effects were found for foot orthosis length and participant group in second peak knee adduction moment (p = 0.028) and knee adduction moment impulse (p = 0.036). Significant interaction effects were found between orthotic length and wedging condition for second peak knee adduction moment (p = 0.002). No significant changes in first knee flexion moment were found. Individual heterogeneous responses to foot orthosis conditions were observed for first peak knee adduction moment, second peak knee adduction moment and knee adduction moment impulse. Biomechanical response is highly variable with personalised foot orthoses. Findings indicate that the tailoring of a personalised intervention could provide an additional benefit over standard interventions and that a three-dimensional printing approach to foot orthosis manufacturing is a viable alternative to the standard methods.
Introduction
Osteoarthritis (OA) is one of the most prevalent musculoskeletal joint conditions throughout the world. In the United Kingdom alone, it is estimated that more than 4.7 million people over the age of 45 years have sought treatment from their general practitioner for knee osteoarthritis (KOA). 1 As a weight-bearing joint, the knee is highly susceptible to OA, with the medial compartment of the knee joint more commonly affected. An increased incidence of medial compartment knee osteoarthritis (mKOA) has been attributed to the combination of greater varus alignment 2 and the higher percentage of overall joint load being transmitted across the medial compartment compared to the lateral compartment (approximately 70:30). 3 Direct measurement of knee joint load is complex, with most in vivo contact loading studies restricted to case studies, and conducted using instrumented prostheses following knee replacement surgery. [4] [5] [6] [7] [8] For noninvasive studies, the knee adduction moment (KAM) is routinely adopted as a surrogate measure whereby it is used to infer the dynamic load placed on the compartments of the knee. 3, 9, 10 This external moment is mainly determined by the ground reaction force vector and its lever arm to the centre of the knee joint. Using this measure, increased KAMs reflect greater medial compartment loading.
Foot orthoses (FOs) incorporating lateral wedges are routinely issued for individuals with mKOA. These are intended to assist in the control and management of the disease by redistributing the total knee joint load across the joint during weight-bearing tasks, alleviating load on the affected medial compartment. They function by causing an increased valgus moment at the ankle, which causes a lateral shift of the centre of pressure at the foot. This lateral shift causes the lever arm length of the ground reaction force vector relative to the knee joint origin to reduce, resulting in the theoretical reduction in the KAM.
The use of lateral wedged FOs has been shown to reduce the peak KAM by approximately 4%-12% in KOA cohorts. 11, 12 However, there is growing evidence that the biomechanical response to orthotic intervention is heterogeneous and can, in some individuals, in fact elevate the KAM. Indeed, it has been estimated that 13%-33% of people with mKOA demonstrate a negative response to lateral wedged insoles, despite beneficial effects reported at group level. [12] [13] [14] [15] [16] The majority of randomised controlled trials (RCTs) that have applied FO interventions for mKOA have generally focused on the application of a single intervention device and compared it to a control condition, which varied between studies. 14, 15, 17, 18 It should however be considered that the requirements for a beneficial biomechanical response are likely to be more complex than a straightforward one-size-fits-all intervention. It may be that different design characteristics will be effective in some individuals and not others, especially when the heterogeneity of the OA population is taken into consideration.
Advances in additive manufacturing (AM) have been adopted in orthotic research and development [19] [20] [21] [22] with new products reaching commercial exploitation. AM may be a useful alternative to standard subtractive manufacturing methods because manufacturing parameters can be controlled and accurately reproduced (in comparison to hand fabrication techniques). Research that has combined three-dimensional (3D) surface scanning, computer-aided design and computer-aided manufacturing (CAD/CAM) have produced custom FOs of equivalent quality to traditional methods with improved reproducibility and design standardisation. 23 Furthermore, AM potentially allows small-scale orthotic manufacture of personalised FOs inside the clinic and closer to the patient. The ability to optimise orthotic design is specifically relevant in the mKOA population given the high variability in treatment response. The aim of this study therefore was to evaluate the immediate biomechanical effect, at both group level and individual level when two key design features are altered in personalised FOs: orthotic length and degree of lateral wedging.
Materials and methods

Study design
This cross-sectional observational study was conducted in a human performance laboratory at Glasgow Caledonian University from November 2013 to February 2015. Participants completed all orthotic tests on the same day.
Participants
Approval was obtained from the Institutional Research Ethics Committee at Glasgow Caledonian University. The procedures followed were in accordance with the ethical standards of the aforementioned research committee and with the Helsinki Declaration of 1975, revised in 2000. In total, 20 participants were enrolled in the study, 10 in the mKOA group and 10 in the control group. All participants provided informed, written consent upon enrolment.
A convenient sample of mKOA participants was recruited via email to staff members of departments within the university and their associated friends and family as well as a Musculoskeletal (MSK) rehabilitation research email address which targets the community. Inclusion criteria for the mKOA group were 550 years of age and physician-confirmed unilateral or bilateral mKOA. Inclusion criteria for the control group were 550 years, no history of unilateral/bilateral KOA and have no chronic/stable knee pain in the past 3 months. Exclusion criteria for both groups were body mass index (BMI) 536 kg/m 2 ; history of lower limb, hip or spinal surgery within the past 6 months; any other joint pathology which causes knee pain; received corticosteroid or other injections to or around the knee in the past 6 months; current or past (within 4 weeks) use of oral corticosteroids; any medical condition that may affect walking; current use of wedge insole/custom-made orthotics; and an aggregate Foot Posture Index (FPI) score \ 29 or . 9. 24 This was assessed by a UK Health and Care Professions Council registered podiatrist (M.A.).
FO design and manufacturing
To design the FOs, weight-bearing 3D surface scans of both feet were taken with the foot in a relaxed standing position using an Easy-Foot-Scan 3D scanner (Baltic Orthoservice UAB, Kaunas, Lithuania). The application of 3D scanners to measure characteristics of foot shape has previously demonstrated reduced measurement variability compared to a traditional neutral suspension plaster casting technique, irrespective of clinical experience. 25 The generated 3D model was converted into stl format and then exported into OrthoModel Pro 2013 computer-aided design (CAD) software (Delcam Plc, Birmingham, UK) to undergo the FO design steps. Inter-operator variability for CAD-based orthotic design has been previously demonstrated. 23 Therefore, one CAD user (biomedical engineer) was employed in this study (R.A.). The user received formal CAD training on the specific software platform from a CAD expert (S.T.) with over 3 years' experience of OrthoModel software.
In the software, all FOs were designed using the 'standard orthosis from scan' mode. This mode used the identification of specific anthropometric measurements of the foot model obtained from the foot scans to design the FO. These measurements included forefoot (FF) width (mm), rearfoot (RF) width (mm), orthotic length (mm) and medial arch height (mm). Forefoot width was determined by the locations of the centre of the first and fifth metatarsal heads, rearfoot width based on the medial and lateral aspect of the heel at its widest point and the medial longitudinal arch height was determined by selecting the most proximal point of the arch relative to the plantar surface.
The implementation of these dimensions provided the basis for the model which could then be altered as such based on key design characteristics of degree of wedging and FO length. In the software, degree of wedging was set at extrinsic, lateral (valgus) resulting in alterations to the wedging of the surface in contact with the foot. Position of wedging could be applied to the rearfoot, forefoot or a combination of both to give the required design. FO length was adjusted in the software with finer adjustments being made based on individual foot shape. All FOs had a set default thickness of 3.5 mm with a solid heel component section. This was selected in accordance with routinely applied and generally accepted insole thickness measurements.
In total, eight variations to the neutral design FO were produced and manufactured for the most symptomatic side in the mKOA group, as measured by a visual analogue scale (VAS) scale for pain or randomly chosen for the healthy group. Variations under investigation included both a three-quarter-length and a fulllength FO with the following degrees of wedging: 0°'neutral', 5°rearfoot lateral wedging, 10°rearfoot lateral wedging and combination of 5°forefoot and 10°r earfoot lateral wedging. The non-test leg received a 0°'neutral' posted FO of equivalent length during each test condition to remove any chance of altered gait patterns from differences in FO length. The FO design process took approximately 1.5-2 h for all eight variations per participant. The fabrication time for the eight variations (10 insoles per participant; one set of neutral full length, one set of neutral three-quarter length and the six variations of the assigned test leg) was approximately 70-120 h, depending on participants' shoe size.
Fused deposition modelling
All FOs were manufactured via a fused deposition modelling (FDM) approach using a desktop 3D printing system (3D Touch; Bits from Bytes, Clevedon, UK). FDM is a method of AM first patented and trademarked by Stratasys Inc. which involves building a 3D object layer-by-layer. Also commonly referred to as plastic jet printing (PJP) and fused filament fabrication (FFF), recently, this method has become open sourced, resulting in a more consumer-driven application and increased number of marketed products. The 3D printing system used was a commercially available 3D printer and although its application is not specific to FO manufacturing, it had previously been used in similar published studies by this group. 23, 26 FOs were manufactured in a soft polylactide (PLA) thermoplastic with material properties conducive to producing semi-rigid FOs (www.orbi-tech.de; density: 1.35 g/cm 3 , tensile strength: 16 MPa, strain at yield: 290%, Young's modulus: 380 MPa, shore hardness: 92 A). PLA FOs have been successfully employed by this group in other studies. 23, 26 Axon 2 software (Bits from Bytes, Clevedon, UK) was used to prepare the FOs for printing. The software functioned by mathematically slicing the FO into layers and creating the toolpaths for the 3D printer to follow. Build settings used to print the FOs involved a layer height of 0.25 mm, fill density of 52% and a printing temperature of 195°C with the inclusion of a printed raft and support material.
The FDM process of the 3D printing system ( Figure 1 ) functioned by feeding the thermoplastic material at a set feed rate (16 mm/s) through a temperature-controlled nozzle head. Once in contact with the heating element inside the nozzle, the solid thermoplastic filament was heated to its melting temperature, altering its structure into a molten, semiliquid state. The nozzle travelled in the X and Y directions and extruded the molten thermoplastic material at a set flow rate (20 r/min) according to the toolpath for the layer, creating a cross-sectional two-dimensional (2D) layer on the build platform. Once complete, the build platform was lowered by a set height (0.25 mm) and the next cross-sectional layer printed. During this process, the two layers were bonded together through thermal fusion and then solidified together as the layers cooled down. This process was repeated for each of the toolpath layers until the FO was complete. Once printed, support structures and rafts were manually removed. FOs were hand-finished using sandpaper to create a smooth surface for comfortable FO fit and use.
Measurements
Participants were tested in their own footwear to replicate their normal daily wear and comfort levels. A foursegment unilateral model was created for the test leg using a modified version of the Cleveland Clinic marker set. This included markers placed bilaterally on the anterior and posterior superior iliac spine and greater trochanters. Additionally, for the test leg, markers were placed on the lateral femoral condyle, lateral malleolus, and on the shoe itself, over the posterior calcaneus, first metatarsal head and the fifth metatarsal head. To track the thigh and shank segments, shell-mounted clusters of four tracking markers were placed on the lateral aspects of these segments. During the initial static standing trial, additional markers were placed on the medial femoral condyle and medial malleolus to determine relative positioning of joint centres and were removed for dynamic trials.
For trials, a 14-camera motion capture system (Qualisys AB, Gothenburg, Sweden) operating at a frequency of 120 Hz was used to capture the retroreflective markers. Simultaneously, a force plate (9286B; Kistler, Winterthur, Switzerland) embedded into the walkway was used to measure the ground reaction forces at 2400 Hz. These data capturing methods are standard practices in research investigating the biomechanics of human movement.
After an initial FO fitting session and accommodation period of approximately 1 week, participants returned to the laboratory for the main evaluation. A static trial was recorded with the participant standing in the shod condition and then anatomical markers were removed prior to collection of dynamic trials.
Walking trials were measured for the shod condition followed by eight FO conditions. Testing order was randomised for each participant to avoid order effects, and participants were blinded to the condition during testing.
Participants were given time to acclimatise to each FO until a consistent gait pattern was observed. They were then asked to walk along the walkway until a total of seven successful force plate strikes with the test leg were recorded. Walking speed was standardised to within 610% of their self-selected walking speed during the shod test using photoelectric timing gates (Brower timing system, Draper, UT, USA). A rest period was included between FO conditions to reduce potential effects of fatigue.
Knee joint moments were calculated from inverse dynamic analysis using Visual 3D software (C-motion Inc., Germantown, MD, USA). Variables associated with knee joint loading were identified, and analysis was limited to these variables. These included peak KAM during the first half of stance phase (1KAM), peak KAM during the second half of stance phase (2KAM), knee flexion moment during the first half of stance phase (1KFM) and the knee adduction moment impulse (KAMI), that is, integral of the total KAM. Kinetic variables were anatomically referenced to the proximal segment. All variables of interest were normalised by dividing body weight multiplied by height and then expressed as a percentage (for 1KAM, 2KAM and 1KFM, this was N m/(% body weight 3 height); for KAMI, this was (N m/s)/(% body weight 3 height). This normalisation approach allowed for the effects of height and body weight to be considered factors which significantly influence joint kinetics. 27 The mean of the final five successful walking trials from each test condition with complete marker tracking was used in the analysis. Marker trajectories and Ground Reaction Force (GRF) data were low passed filtered with a fourth-order Butterworth filter at 6 and 25 Hz, respectively.
Statistical analysis
Statistical analyses were performed with SPSS (Norusis/SPSS, Chicago, IL, USA) using a level of 0.05. Data were checked for normality, through Shapiro-Wilk's tests, prior to analysis. All kinetic variables used in the analysis indicated normally distributed results. For analysis, all variables were defined relative to the shod condition, considered the baseline for the study and evaluated using a three-factor, repeated-measures analysis of variance (ANOVA) to determine the main effect for group, length, wedging type and any interaction effects.
Results
Demographic characteristics of study cohorts are presented in Table 1 . The mKOA group was significantly older and had a higher BMI than the healthy control group.
Mean 1KAM, 2KAM, 1KFM and KAMI values for each condition and group are presented in Table 2 .
ANOVA results on all test variables are presented in Table 3 . Variable definitions include main effects of orthotic length (three-quarter length/full length), group (mKOA/control group) and wedging (0°'neutral', 5°rearfoot wedging, 10°rearfoot wedging and a combination of 5°forefoot 10°rearfoot wedging). Interaction effects between these variables are also provided.
1KAM
Significant main effects were found for orthotic length in 1KAM (p = 0.038). At the group level, both FO lengths provided mean overall reductions in 1KAM compared to shod condition (Figure 2 ). This corresponded to a mean 6 standard deviation (SD) percentage reduction in peak KAM in the first half of stance of 1.1% 6 12.3% for the three-quarter-length FOs and 2.8% 6 12.4% for the full-length FOs.
Wedging condition was also found to be statistically significant for 1KAM (p \ 0.001). With the exception of the neutrally posted FOs (2% 6 11.3% increase), 1KAM was reduced for all wedging conditions. This corresponded to a mean 6 SD percentage reduction in 1KAM of 2.3% 6 9.2%, 4% 6 8.3% and 3.5% 6 8.7% for the 5°rearfoot, 10°rearfoot and combined 5°f orefoot/10°rearfoot wedging conditions, respectively.
No significant interaction effects were found between the length of orthotic and level of wedging. Furthermore, no significant difference existed between the mKOA and healthy group.
2KAM
Significant main effects were found for orthotic length in 2KAM (p = 0.018). At the group level, both FO lengths provided a mean overall increase in 2KAM compared to the shod condition ( Figure 3 ). This increase corresponded to a mean 6 SD percentage increase in 2KAM of 6.5% 6 16.9% for the three-quarter-length FOs and 4.1% 6 19.1% for full-length FOs.
An interaction effect was also found between FO length and group (p = 0.028). For the mKOA group, these differences corresponded to mean 6 SD percentage changes of 2.9% 6 16.9% and 2.7% 6 19.1% for the three-quarter-length FOs and full-length FOs, respectively. The healthy group showed greater increase in 2KAM corresponding to mean 6 SD percentage changes of 10.2% 6 16.9% and 5.5% 6 19.1% for the three-quarter-length FOs and full-length FOs, respectively.
Significant main effects were found for wedging for 2KAM (p \ 0.0001). Irrespective of the orthotic length, FOs had a somewhat negative effect on 2KAM, corresponding to mean 6 SD percentage increase in peak 2KAM of 9.5% 6 12.9%, 5.8% 6 12.5% and 6.1% 6 15.6% for the neutral, 5°rearfoot and 10°rearfoot wedging conditions, respectively. No significant differences were found between OA and the healthy groups. Furthermore, significant differences existed between the combined 5°forefoot and 10°rearfoot FO, considering the most biomechanically aggressive FO and all other wedging conditions. For this condition, when compared to other wedging conditions, there was a reduction of 9.6%, 5.9% and 6.6% when compared to the neutral, 5°rearfoot, 10°rearfoot wedging conditions, respectively. However, compared to the shod condition, it only produced a minimal 2KAM reduction of 0.1% (13.4) .
Other significant interaction effects were found between orthotic length and wedging condition for 2KAM (p = 0.002). For the three-quarter-length FOs, alterations to wedging corresponded to mean 6 SD percentage changes of 9.1% 6 10.1%, 6.6% 6 9.5%, 5.9% 6 10.6% and 4.5% 6 9.6% for the neutral, 5°r earfoot, 10°rearfoot and combined 5°forefoot/10°r earfoot wedging conditions, respectively. Full-length FOs demonstrated a similar dose response with the exception of combined 5°forefoot/10°rearfoot wedging condition, corresponding to mean 6 SD percentage changes of 9.9% 6 9.2%, 5% 6 10.3%, 6.3% 6 12.6% and 24.8% 6 12.3% for the neutral, 5°rearfoot, 10°rearfoot and combined 5°forefoot/10°T rearfoot wedging conditions, respectively. No significant differences were found between mKOA and the healthy group in relation to 2KAM.
1KFM
For 1KFM, no significant main effects or any interaction effects were found. Although no statistically significant findings were evident (p = 0.109) between the groups, the mKOA group demonstrated a mean 6 SD 1KFM increase of 11.4% 6 26.6% compared to the healthy group, 4.3% 6 26.6% (Figure 4 ).
KAMI
Significant main effects were found for orthotic length in KAMI (p = 0.022). Irrespective of the group, the FO length provided different responses in terms of the KAMI compared to the shod condition ( Figure 5 ). This corresponded to a mean 6 SD KAMI percentage change of 2.1% 6 16.8% for three-quarter-length FOs and 0.4% 6 16.1% for full-length FOs. Significant interaction effects were found between orthotic length and group (p = 0.036). For the mKOA group, this corresponded to a mean 6 SD KAMI percentage change of 20.5% 6 16.3% and 20.7% 6 16.1% for the three-quarter-length-FOs and full-length FOs, respectively, compared to the healthy group who demonstrated an increase in KAMI of 4.6% 6 16.3% and 1.5% 6 16.1% for the three-quarter-length FOs and full-length FOs, respectively.
Significant main effects were found for wedging for KAMI (p \ 0.0001). Irrespective of group, the effect of wedging condition corresponded to mean 6 SD percentage changes of 5.9% 6 10%, 0.9% 6 11%, 0.9% 6 9% and 22.6% 6 10% for the neutral, 5°rearfoot, 10°rearfoot and combined 5°forefoot/10°rearfoot posted conditions, respectively.
Although borderline, the interaction between wedging and orthotic length was not significant (p = 0.055). For the three-quarter-length FOs, alterations to wedging corresponded to mean 6 SD percentage changes of 3% 6 13%, 1% 6 9% and 0% 6 9% for the 5°rearfoot, 10°rearfoot and combined 5°forefoot/ 10°rearfoot wedging conditions, respectively. The fulllength FO demonstrated a slightly different pattern corresponding to mean 6 SD percentage changes of 2% 6 9%, 10% 6 2% and 26% 6 10% for the 5°r earfoot, 10°rearfoot and combined 5°forefoot/10°r earfoot wedging conditions, respectively.
Individual response
The variable magnitude of response to orthotic changes across the biomechanical outcome measures is evident when the high SDs and confidence intervals are considered. The variability in biomechanical response was present in both groups. mKOA: medial compartment knee osteoarthritis; SD: standard deviation; CI: confidence interval; 1KAM: first peak knee adduction moment; 2KAM: second peak knee adduction moment; 1KFM: first knee flexion moment; KAMI: knee adduction moment impulse.
Negative and positive responses to FOs were assessed in relation whether the percentage increase/ decrease was greater/less than the reported standard error of the mean (SEM) for each variable. For 1KAM, 22/80 (27.5%) of the assessments, incorporating the various wedging conditions for the mKOA group, resulted in a negative biomechanical response over the SEM. The healthy group had an incidence of 22/80 (27.5%) negative responses. A positive 1KAM response above SEM was found in 44/80 (55%) for both mKOA and healthy groups. For the 2KAM, 41/80 (51.3%) of assessments for the mKOA group caused an inverse biomechanical response over the SEM. This is compared to 58/80 (72.3%) negative responses for healthy group. A positive 2KAM response above SEM was found in 25/80 (31.3%) and 15/80 (18.8%) for mKOA and healthy groups, respectively. For KAMI, 29/80 (36.3%) of the assessments for the mKOA group demonstrated an inverse biomechanical effect over the SEM. This is compared to 42/80 (52.3%) for the healthy group. In relation to a positive KAMI response, a reduction below the SEM was found in 34/80 (42.5%) and 25/80 (31.3%) for mKOA and healthy groups, respectively. For 1KFM, overall 50/80 (62.5%) assessments demonstrated an increase in 1KFM in response for the mKOA group over the SEM. The healthy group demonstrated increased 1KFM in 43/80 (53.8%), whereas a reduction in 1KFM was reported in 13/80 (16.3%) and 20/80 (25%) for mKOA and healthy groups, respectively.
Discussion
The aim of this study was to investigate alterations in knee joint kinetics as a result of modifications in design features of personalised FOs. Our findings suggest that when two key design features are altered, there is a significant heterogeneous mechanical response observed at the knee joint in both the OA and healthy groups during walking. These results enhance our knowledge and understanding as to the potential benefits of personalising FO interventions in order to provide a more positive immediate biomechanical effect even when a heterogeneous biomechanical response exists between conditions for individuals. At the group level, the full-length FOs caused a significant reduction in 1KAM compared to the threequarter-length FOs, indicating a better response to fulllength FOs by both study groups. These findings are similar to those previously reported that wedging applied to the entire lateral border is more effective at reducing 1KAM than just at the heel. 15 Although significant effects of wedging were found for 2KAM, the majority of conditions resulted in elevated values, indicative of greater medial compartment loading. Overall, the reduction in 1KAM did not correspond to a reduction in 2KAM for most conditions. However, there was a reduction in 2KAM for the three-quarter-length FOs and the full-length FOs which incorporated 5°forefoot/10°rearfoot wedging. For these conditions, mean 2KAM reduced by 0.5% and 4.7%, respectively, relative to shod in the mKOA and healthy group, respectively. These reductions in 2KAM are similar to previously reported results. 15, 28 During the majority of the second period of stance, the forefoot is the only component in contact with the ground. Biomechanically, it is hypothesised that wedging the entire forefoot section will further increase the rearfoot eversion moment, through an increase in its lever arm length across a longer period of the stance phase. Significant correlations have been reported between increased rearfoot eversion moments and reduced KAM moments. 29 As such, increasing the overall period at which the FO is 'biomechanically effective' for therefore makes sense and has been reported to be a key design feature to reduce KAM variables. 15 No significant main or interaction effects were found for 1KFM; however, it was evident that the lateral wedged orthotics provided a concomitant elevation of 1KFM across all FO conditions compared to the shod. The fact that no significant effects were found between FO conditions suggests that these increases may be attributable to the orthotic design itself. Walter et al. 6 suggested that a corresponding increase in KFM may attenuate any load reducing the benefit of KAM reductions. In this study, our FOs caused a general elevation in 1KFM of 11.4% in the mKOA group, compared to 4.3% the healthy group (overall in~77.5% of all participant responses); therefore, it remains unclear as to whether a reduction in medial contact force would have occurred even with the reported reductions in 1KAM and KAMI variables.
KAMI has been suggested as a more suitable measure to infer the loading of the medial compartment 30, 31 as it takes into consideration both the amplitude of the moment and the total period of stance. For the mKOA group, KAMI was reduced by all FOs which incorporated lateral wedging. The full-length FO which incorporated 5°forefoot/10°rearfoot wedging was found to be the most biomechanically effective FO. For this condition, mean KAMI reduced by 4.9% relative to shod. Given a slightly longer walking time, it could be argued that the elevated 2KAM values reported could have translated into the KAMI; however, rearfoot wedged conditions, which reported increased 2KAM, demonstrated reductions in KAMI indicating that overall loading still reduced.
The reductions in KAMI in response to lateral wedged FOs are in line with those previously reported in the literature. 32, 33 These findings reinforce the suggestion that FOs incorporating increased wedging across the full length of the lateral side will result in a greater reduction in cumulative load on the knee joint throughout the stance phase. However, these findings were found at the group level which demonstrated a high level of variability. It is important to note that other aspects such as individual response to pain and tolerance to FO condition have to be taken into consideration when the severity of lateral wedging is targeted.
In this study, the variability between subjects in the knee joint loading characteristics of 1KAM, 2KAM and KAMI in response to the FO conditions appears greater to that reported in previous research. Hinman et al. 32 reported a negative response in 23% of participants with a 5°lateral wedge. In the mKOA group alone, across the variables linked to medial compartment loading, a negative response was evident and to a greater extent when FO conditions were grouped together, corresponding to an incidence of 27.5%, 51.3% and 36.3% negative responses over the SEM for 1KAM, 2KAM and KAMI, respectively. Furthermore, for the 5°lateral forefoot/10°lateral rearfoot wedged FO, considered the most biomechanically aggressive for reducing medial tibiofemoral compartment loading, participants in both the mKOA group (2/10) and healthy group (3/10) experienced an increase in 1KAM compared to shod that was above the conditions SEM. One possible explanation to this variability is that the immediate assessment of the multiple variations in FO design may have exaggerated these negative effects compared to other studies which have tended to examine only one FO variation.
The FO sector has realised the potential capabilities of AM and FO design methods. The methods adopted in this study offer a complete digital design and manufacturing solution that potentially overcomes the limitation of traditional subtraction manufacturing. For our study, the average time between participants' fitting sessions and final assessment was approximately 25 days. This however does not reflect clinical practice where patients are typically supplied with one pair of devices. Manufacturing time of the eight remaining insoles only took approximately 56-96 h print time (2 per day, approximately 4-5 days). Furthermore, the period between initial scan and printing of the neutral FOs for the acclimatisation session was as short as 2 days, but was dependent on total manufacturing volume. Traditional methods including plaster casting, however, often involve more cumbersome processes which require additional time, particularly during the manufacturing stage. 34 Future difficulties lie in the practical feasibility of integrating 3D design and manufacturing technologies into the clinical environment in a way which will optimise patient care, drive down overhead costs for health organisations and reduce the turnaround period between initial assessment and FO issue. Furthermore, the feasibility of a truly personalised device for each individual using this approach still requires further assessment. The creation of a more streamlined approach to the process is required in order to effectively tailor the personalised intervention to the point that it can be confidently predicted that the intervention will provide a beneficial effect.
Limitations and conclusion
There are a number of limitations which warrant further discussion. First, participants were instructed to wear their own current trainer rather than a standardised shoe during testing. This may have contributed to the variability in biomechanical response, based on the differences in mechanical characteristics of the footwear, which could influence individual gait patterns. However, this approach was taken to reflect what participants would wear on a daily basis and was assumed not to disrupt their normal biomechanical gait pattern based on their routine use. Furthermore, as results are expressed relative to a shod test condition, this confounding factor is theoretically minimised in the results. We believe the methods applied in this study provide valid results while maintaining a pragmatic approach to an intervention study.
The cross-sectional nature of the study focused on the immediate biomechanical response, with testing of each FO performed in a random order with little acclimatisation period. It is unclear whether each of the conditions evaluated would have had a different effect if they were worn over an extended period of time.
Turpin et al. 35 reported that an extended period of wear would allow suitable acclimatisation to an FO design to occur. However, the immediate biomechanical effect can provide a valuable indicator for long-term clinical outcomes. Hinman et al. 36 demonstrated a significant correlation between immediate first peak KAM reductions with lateral wedged FOs and improvements in The Western Ontario and McMaster Universities Arthritis Index (WOMAC) function score at 3-month follow-up, whereby individuals who demonstrated a greater reduction in the adduction moment reported less physical disability.
The OA population is known to be heterogeneous in nature. These findings of variability in response to orthotic intervention in people with mKOA further support the requirement to develop a better understanding of responders/non-responders, perhaps based on other biomechanical and physical characteristics such as altered ankle joint motions. 13 To our knowledge, this study is the first to examine the immediate biomechanical response to multiple designs of personalised FOs in an mKOA group. These findings suggest that a blanket approach to orthotic prescription may not be an effective treatment plan irrespective of the perceived benefit at the group level. This may go some way to explain the negative findings from recent RCTs of this type of intervention and is a crucial consideration for the KOA population where orthotic prescription is routine practice. In theory, under these methods, there could be individuals with KOA who are being prescribed FOs which cause increased KAMs possibly exacerbating their OA progression. A greater understanding is required as to which individuals respond to an orthotic intervention, that is, responder characteristics, as well as improving the ability to optimise the biomechanical response for each of these individuals. Difficulties lie in how we identify these 'responsive' individuals early so that interventions can be implemented for long-term benefit. Chapman et al. 13 reported that the biomechanics of the ankle/subtalar joint complex plays a central role in KAM reduction and could perhaps predict those who are more likely to have a positive response. Furthermore, Paterson et al. 37 recently reported a strong relationship between foot and knee pain in people with KOA, resulting in adverse effects on health outcomes and functionality. Future research requires the integration of in-depth biomechanical analyses as well as additional clinical and risk factor assessments to identify and perhaps predict FO responders. Increased involvement of the individual into this process may also be an important consideration.
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